Sandoz, a multinational pharmaceutical company, announced on September 18 that it would stop worldwide distribution of all Ranitidine-containing medicines, including the largest prescribed drug Ranitidine at one time, because of potentially carcinogenic impurity NDMA in this anti acid medication. Soon thereafter the Drug Controller General of India also followed suit.
Ranitidine belongs to a group of drugs called histamine-2 or H-2 blockers, which decrease stomach acid but do not make it zero.
Read Latest News and Breaking News at The Quint, browse for more from fit
Published:


